Application | Comment | Organism |
---|---|---|
medicine | tumor cell motility-stimulating factor | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1,10-phenanthroline | 0.5 mM | Homo sapiens | |
D-histidine | 15 mM, 75% inhibition | Homo sapiens | |
EDTA | 10-20 mM | Homo sapiens | |
L-histidine | 15-20 mM, noncompetitive, 75% inhibition, inhibition can be reversed by 20fold lower concentrations of zinc or cobalt salts | Homo sapiens | |
L-histidine amide | 15 mM, 20% inhibition | Homo sapiens | |
L-histidine methylester | 15 mM, 65% inhibition | Homo sapiens | |
N-methyl-L-histidine | 15 mM, 30% inhibition | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.47 | - |
lysophosphatidylcholine | in presence of 0.25 mM Zn2+ plus 10 mM L-histidine | Homo sapiens | |
0.49 | - |
lysophosphatidylcholine | - |
Homo sapiens | |
0.55 | - |
lysophosphatidylcholine | in presence of 0.25 mM Zn2+ | Homo sapiens | |
0.66 | - |
lysophosphatidylcholine | in presence of 10 mM L-histidine | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Purification (Comment) | Organism |
---|---|
prepared from a Vaccinia viral lysate through the concanavalin A-agarose step | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
lysophosphatidylcholine + H2O | - |
Homo sapiens | lysophosphatidic acid + choline | - |
? |
Synonyms | Comment | Organism |
---|---|---|
ATX | - |
Homo sapiens |
autotaxin | - |
Homo sapiens |
LPLD | - |
Homo sapiens |
lysophospholipase D | - |
Homo sapiens |
NPP-2 | - |
Homo sapiens |